CHINA PHARMA HOLDINGS, INC. (CPHI) › RevenueCHINA PHARMA HOLDINGS, INC. (CPHI) — RevenueAnnual figures by fiscal year, from SEC filings.2010: $74.39M2011: $81.17M2012: $54.51M2013: $32.81M2014: $22.13M2015: $20.35M2016: $15.57M2017: $13.21M2018: $12.33M2019: $10.92M2020: $10.87M2021: $9.64M2022: $8.10M2023: $7.01M2024: $4.53M2025: $4.14M$4.14M2010Revenue (USD)2025Fiscal YearRevenueChange YoY2025$4.14M-8.5%2024$4.53M-35.4%2023$7.01M-13.5%2022$8.10M-15.9%2021$9.64M-11.3%2020$10.87M-0.5%2019$10.92M-11.4%2018$12.33M-6.7%2017$13.21M-15.1%2016$15.57M-23.5%2015$20.35M-8.1%2014$22.13M-32.5%2013$32.81M-39.8%2012$54.51M-32.8%2011$81.17M+9.1%2010$74.39M—Other metrics: Cost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share